TrianglePUBLICATIONS · 8004585
Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 1994 Jul 1
- First author
- Anelli TF
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Anelli TF
- type
- Author
- name
- Anelli A
- type
- Author
- name
- Tran KN
- type
- Author
- name
- Lebwohl DE
- type
- Author
- name
- Borgen PI
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Anelli TF
- type
- Author
- name
- Anelli A
- type
- Author
- name
- Tran KN
- type
- Author
- name
- Lebwohl DE
- type
- Author
- name
- Borgen PI
- type
- Author
- bibliography ids
- nci-bib-0ed430aa40d85531c80d16ba
- book metadata
- content sha256
- 69075c7ef1f28481e96ccf7fb5b24db7c059b4c18c86aa54b99da7bf5fa4f24a
- document type
- citation
- dois
- 10.1002/1097-0142(19940701)74:1<74::aid-cncr2820740113>3.0.co;2-#
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:8004585
- immutable id
- pubmed:8004585@69075c7ef1f28481e96ccf7fb5b24db7c059b4c18c86aa54b99da7bf5fa4f24a
- journal
- abbreviation
- Cancer
- issn electronic
- Source null
- issn print
- 0008-543X
- issue
- 1
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 74-7
- volume
- 74
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 8004585
- provenance
- batch id
- 113cd9a3f1a8bf48d098
- provider
- NCBI PubMed ESummary
- record sha256
- 0fd0185f736a08d7d8f4003d96aaddfb815f3acc5aed841c923b91e8e017609e
- response sha256
- 7ff1f3e7d59b211257eb2c865c0b20a1c75138ebda6e11a58279b514a06be809
- retrieved at
- 2026-09-09T23:45:18.960722+00:00
- publication date
- display
- 1994 Jul 1
- precision
- day
- year
- 1994
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/8004585/
- title
- Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients.
Preserved source evidence · Not medical advice